Pale Fire Capital SE bought a new stake in aTyr Pharma, Inc. (NASDAQ:LIFE – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 55,857 shares of the biotechnology company’s stock, valued at approximately $88,000. Pale Fire Capital […]
Shares of aTyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the six analysts that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year […]
aTyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the six brokerages that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 year price […]
StockNews.com lowered shares of aTyr Pharma (NASDAQ:LIFE – Free Report) from a hold rating to a sell rating in a research note released on Saturday morning. Separately, HC Wainwright reaffirmed a buy rating and issued a $35.00 price objective on shares of aTyr Pharma in a research report on Thursday, September 21st. One research analyst […]
aTyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) has earned an average recommendation of “Moderate Buy” from the six research firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month price objective among […]